Search results
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Benzinga· 5 days agoThursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within the ViraxImmune T-Cell diagnostic platform for research-use-only (RUO) at the European Society ...
Immunologist receives biomedical research award | Cornell Chronicle
Cornell News Service· 5 days agoAshley Nelson, assistant professor of immunology research in the Department of Pediatrics at Weill...
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Investing.com· 5 days agoEXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Big Pharma's Blockbuster Creation Continues to Disappoint
Mercola· 6 days agoMessenger ribonucleic acid (mRNA) vaccines are being described as a "new era in vaccinology."1 Research is underway to develop mRNA shots for not only coronaviruses but also C. difficile, hepatitis ...
Texas Biomed researching vaccines and treatments for highly pathogenic avian influenza
Newswise· 4 days agoResearchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains ...
Vilya Announces New Publication in Science Validating Foundational Approach to Design of Novel...
Morningstar· 5 days agoVILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely targets disease biology, today announced the publication of a new study in Science that validates ...